Author:
Mikhail Andrew S.,Levy Elliot B.,Krishnasamy Venkatesh P.,Woods David L.,Esparza-Trujillo Juan A.,Bakhutashvili Ivane,Banovac Filip,Wakim Paul G.,Negussie Ayele H.,Tang Yiqing,Henman Alexander,Willis Sean L.,Karanian John W.,Pritchard William F.,Lewis Andrew L.,Wood Bradford J.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging
Reference30 articles.
1. Fiorentini G, Aliberti C, Tilli M, Mulazzani L, Graziano F, Giordani P, Mambrini A, Montagnani F, Alessandroni P, Catalano V, & Coschiera P. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: Final results of a phase III study. Anticancer Res. 2012;32(4):1387–95.
2. Xu G, Zhang W, Ma MK, McLeod HL. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. Clin Cancer Res Off J Am Assoc Cancer Res. 2002;8(8):2605–11.
3. Guichard S, Terret C, Hennebelle I, Lochon I, Chevreau P, Fretigny E, et al. CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues. Br J Cancer. 1999;80(3–4):364–70.
4. Forster RE, Small SA, Tang Y, Heaysman CL, Lloyd AW, Macfarlane W, et al. Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer. J Mater Sci Mater Med. 2010;21(9):2683–90.
5. Lewis AL, Hall B. Toward a better understanding of the mechanism of action for intra-arterial delivery of irinotecan from DC Bead (DEBIRI). Future Oncol. 2019;15(17):2053–68.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献